The molecular and cell biology of the alphavirus Semliki Forest virus (SFV) have been extensively studied, as has the pathogenesis of SFV infection in laboratory mice (6, 10) . Generally, the virus is neuroinvasive, and extraneural inoculation results in a high-titer plasma viremia with infection of central nervous system (CNS) cells by virus passage across the bloodbrain barrier (24, 25, 11, 36) . Strains of SFV vary in their neurovirulence in adult mice. Irrespective of the route of inoculation, adult mice infected with the L10, V13, or prototype strains or virus derived from the prototype molecular clone SFV4 rapidly succumb to a fulminant encephalitis, whereas adult mice infected with the A7 or A7(74) strain develop a subclinical encephalitis (8, 27) . The nominally avirulent strains spread more slowly in the CNS, and host responses prevent widespread fatal infection and eventually eliminate infectious virus (7, 11) , though they generate lesions of immune-mediated demyelination (12, 37) . In SJL mice these lesions are active for many months (9, 35) . In contrast to their differences in adult mice, all strains of SFV are virulent in embryonic, neonatal, and suckling mice (5, 11, 13, 15) . For the adultavirulent strains A7 and A7(74) there is a sharp age-related transition (22, 23) . In suckling mouse brain and in culture, many infected brain cells rapidly undergo apoptosis (3, 17) , whereas in immunocompromised adult mice, virus can persist in CNS cells without any apparent cell death for many months (4, 12) . Age-related neurovirulence may be related to changes in the propensity of CNS cells to undergo apoptosis on infection (2, 3) .
The SFV4, A7, and A7(74) strains have been cloned and sequenced (14, 16, 31, 32, 39, 40, 41) . Between the strains there are multiple changes scattered throughout the genome (41) . The difference in virulence between SFV4 and A7 or A7(74) appears to be polygenic, and to date, changes in the E2 gene, the 5Ј untranslated region, and the nsP3 gene have been shown to be determinants of virulence between these particular strains (32, 33, 40, 41) . As with all viruses, there will also be many other sites where changes in the genome sequence will affect viral virulence. Interestingly for a positive-strand RNA virus which replicates in the cytoplasm, the SFV nsP2 nonstructural protein has a nuclear targeting signal. This sequence, 648 RRRV (the numbering refers to the SFV4 amino acid sequence), is present in all three cloned and sequenced strains of the virus. In SFV4infected cells about half of the nsP2 synthesized is translocated to the nucleus (19, 26, 29) . nsP2 is involved at a number of stages of viral RNA replication; it has single-stranded-RNAstimulated ATPase and GTPase activities, RNA triphosphatase activity, and RNA helicase activity; it regulates synthesis of the 26S subgenomic RNA; it is involved in the cessation of negative-strand synthesis; and it contains a papainlike proteinase domain responsible for processing the nonstructural polyprotein (18, 20, 30, 38, 42) . The mechanism by which RNA viruses such as SFV trigger the apoptotic response of the infected cell remain unclear; events in the nucleus would be one possibility.
SFV-RDR virus has a single amino acid change, from SFV4 649 R to D, which disrupts the nsP2 nuclear localization signal. The engineering of this virus from the SFV4 cDNA infectious clone has been described previously (28) . In BHK-21 cells transfected with infectious RNA transcribed from the SFV-RDR plasmid, nsP2 expression is confined to the cytoplasm, infected cells have only a partial shutoff of host cell DNA synthesis, and there are only marginal differences in the one-step growth curves of the two viruses (28) . In order to determine the importance of the nsP2 649 R-to-D mutation and to establish whether this has any role in neuroinvasion, neurovirulence, tropism, or ability of the virus to trigger apoptosis, we compared the course of CNS infection in mice infected with SFV-RDR and SFV4.
Four-to six-week-old female BALB/c mice, 129 mice, or 129 mice with a genetic disruption of the alpha/beta interferon receptor gene (21) were kept under specific-pathogen-free conditions in the animal unit at the University of Edinburgh Laboratory for Clinical and Molecular Virology. Two groups of 10 female BALB/c mice were inoculated intraperitoneally with 200 PFU of SFV4 or SFV-RDR in 0.1 ml of phosphatebuffered saline (PBS) containing 0.75% bovine serum albumin. A further two groups of 10 female BALB/c mice were inoculated intracerebrally with 50 PFU of SFV4 or SFV-RDR in 0.025 ml of PBS containing 0.75% bovine serum albumin. Following intraperitoneal inoculation, mice were sampled at days 4 and 7. Following intracerebral inoculation, mice were sampled at days 2, 3, 4, and 7. In all cases, brains were removed and bisected sagitally down the midline. One half of each brain was snap frozen and stored (Ϫ70°C) for the viral infectivity assay, and the other half was immersion fixed in 4% phosphate-buffered formalin before being processed for paraffinbased histology. Plaque assays were performed on subconfluent monolayers of BHK-21 cells as described previously (11) . Paraffin-embedded sections at 5 m were cut onto adhesivecoated slides and immunostained for viral antigens. Prior to immunostaining, to increase sensitivity and resolution, an antigen retrieval step was carried out by heating in a microwave oven in 0.01 M citrate buffer. Sections were then rinsed in PBS, fixed by immersion in paraformaldehyde lysine periodate for 20 min, and digested with proteinase K before immunostaining using a rabbit polyclonal anti-SFV antiserum or staining with the terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) technique prior to immunostaining as described previously (11, 34) .
Following intraperitoneal inoculation with 200 PFU of SFV4 or SFV-RDR, BALB/c mice survived at least 42 days, at which time the study was terminated; these mice did not develop clinical signs during this time. In contrast, BALB/c mice inoculated intracerebrally with SFV4 developed clinical signs within 2 days and were all dead by 4 days (Table 1 ). Intracerebral inoculation of SFV-RDR did not result in any mortality FIG. 1. Brain virus titers determined by plaque assay on BHK-21 cells. Mice were inoculated intraperitoneally (A) or intracerebrally (B) with 200 PFU of SFV4 (q) or SFV-RDR (▫). SFV4 titers were significantly (P Ͻ 0.05) higher than SFV-RDR titers by Student's t test at several time points following inoculation (intraperitoneal inoculation, P ϭ 0.065 and 0.007 on days 4 and 7, respectively; intracerebral inoculation, P ϭ 0.008 and 0.072 on days 2 and 3, respectively). Mice inoculated intracerebrally with SFV4 did not survive after day 3. The limit of detection of the assay was 2.7 log (10) PFU/g of brain. or clinical signs over the 42-day study period. The brain virus titers of the sampled mice are shown in Fig. 1 . Both viruses were neuroinvasive and entered the brain in all animals inoculated intraperitoneally. SFV4 brain virus titers were signifi-cantly higher than SFV-RDR titers for both routes of infection ( Fig. 1) . Immunostaining studies on the distribution and extent of infection in the brain confirmed this finding, with many more cells being infected by SFV4 than by SFV-RDR ( Fig. 2A and B). SFV-RDR virus was restricted to replication in individual cells or small groups of cells scattered throughout the brain (Fig. 2D ). This was particularly apparent following intracerebral inoculation, where foci of infection were most frequent around the needle tract and in the corpus callosum and the deep layers of the cortex close to the site of inoculation. No major differences in virus cell-type tropism were observed. Both viruses infected cells which based on their morphology were clearly neurons, for example, cerebellar Purkinje cells, and cells distributed in chains in the white matter, presumably oligodendrocytes ( Fig. 2C and F) . Neither strain of virus resulted in positive staining of ependymal, meningeal, or choroid plexus cells.
The difference in brain virus titers and the extent of spread of these two viruses was marked and could have resulted from a number of factors. One possibility is that SFV-RDR is incapable of widespread brain infection; alternatively, there could have been insufficient time for this virus to become widespread before its control by host responses. To distinguish between these possibilities, the course of SFV4 and SFV-RDR infection was investigated in groups of 10 alpha/beta interferon receptor knockout (IFN-␣/␤-R 0/0 ) and parental (wild-type) 129 mice (21) . Disruption of the single alpha/beta interferon receptor results in an absence of alpha/beta interferon responses. Intraperitoneal inoculation of 200 PFU of SFV4 into IFN-␣/␤-R 0/0 mice resulted in death of all mice within 3 days with minimal brain infection, whereas intraperitoneal inoculation of 200 PFU of SFV-RDR into IFN-␣/␤-R 0/0 mice resulted in death between 4 and 6 days. As with BALB/c mice, wild-type 129 mice, which have an intact interferon system, survived intraperitoneal infection with both strains of virus (Table 1) . Examination of the brains of moribund SFV-RDR-infected IFN-␣/␤-R 0/0 mice at 5 days revealed widespread infection in the frontal cortex ( Fig. 2G ), brain stem, pons, and thalamus with infection of ependymal cells, meningeal cells, cerebellar Purkinje cells, cerebellar granule cells, and oligodendrocytes.
In adult mouse brain, in the absence of appropriate immune responses the avirulent SFV A7(74) strain can persist for many months (4, 12) , and in contrast to the situation in the developing brain, infected cells do not undergo apoptosis (2) . To ascertain whether SFV4 infection of adult brain cells results in apoptosis and whether the nsP2 649 R-to-D mutation changes this situation, brain sections were stained by the TUNEL technique to detect apoptotic cells and immunostained to detect virally infected cells. Sections of SFV A7(74)-infected neonatal mouse brain were used as positive controls and showed clear TUNEL staining ( Fig. 2E) , as shown previously (3) . Fixed cultures of SFV4-and SFV-RDR-infected BHK-21 cells were also double labeled. In both the SFV4-and SFV-RDR-infected adult BALB/c mouse brains, the majority of SFV protein-positive cells had the morphologic appearance of neurons and showed enlarged palely staining nuclei (Fig. 2F ). None of these infected cells were TUNEL positive. Double labeling was also carried out on sections from the brains of SFV-RDRinfected IFN-␣/␤-R 0/0 mice, and again, neurons with enlarged palely staining nuclei but no TUNEL-positive infected cells were observed (Fig. 2G) . In contrast to mature neurons, both SFV4-and SFV-RDR-infected BHK-21 cells exhibited TUNEL-positive nuclei (Fig. 2H ). These results demonstrate that an intact RRR nuclear localization sequence is not re-quired for triggering of apoptosis in SFV-infected BHK-21 cells or for the reduced apoptosis observed in SFV-infected adult brain neurons.
In conclusion, an intact nsP2 649 RRR sequence is not required in cultured BHK-21 cells for apoptosis or in adult mice for neuroinvasion, determination of CNS cell tropism, or inhibition of apoptosis. In contrast, an intact nsP2 RRR sequence enhances spread of virus in the mature mouse brain, exacerbating neuropathology and increasing virulence. Thus, a single mutation in the multifunctional RNA replicase protein can limit virus spread in the brain, indicating the importance for pathogenesis of events associated with RNA replication or nsP2 nuclear transport. The nsP3 replicase protein has been shown to be important in the attenuated neurovirulence of the A7(74) strain of SFV (41) . We recently constructed an SFV mutant with an internal deletion in nsP3 which also has attenuated neurovirulence in mice (43) . Further support for the importance of RNA replicase components in neuropathogenesis comes from the observation that inhibition of palmitoylation of nsP1 also attenuates SFV neurovirulence (1) . Our present results obtained with mice with no functional alpha/ beta interferon system show that mutation of the nsP2 RRR sequence does not prevent virus spread but results in a lower rate of spread. Thus, RNA replication as such is not inhibited, but it may be slowed sufficiently in neuronal cells for the interferon system to limit the infection. This effect could also underlie the attenuating changes in nsP1 and nsP3. Further characterization of these mutant viruses in neuronal cultures as well as in immunodeficient mice is needed to identify the role of the RNA replication apparatus in the neuropathogenicity of this virus.
